These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 393728)

  • 1. Clinical evaluation of spiramycin and erythromycin in control of periodontal disease.
    Mills WH; Thompson GW; Beagrie GS
    J Clin Periodontol; 1979 Oct; 6(5):308-16. PubMed ID: 393728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spiramycin].
    Lamy L; Landry RG; Roy S
    J Can Dent Assoc; 1989 May; 55(5):393-5. PubMed ID: 2659147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spiramycin as a selective dental plaque control agent. Laboratory data.
    Rozanis J; Johnson RH; Haq MS; Schofield ID
    J Periodontal Res; 1979 Jan; 14(1):55-64. PubMed ID: 153962
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of spiramycin and tetracycline used adjunctively in the treatment of advanced chronic periodontitis.
    Chin Quee T; Al-Joburi W; Lautar-Lemay C; Chan EC; Iugovaz I; Bourgouin J; Delorme F
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():171-7. PubMed ID: 3182440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antipneumococcal activity of erythromycin and spiramycin in 2 experimental models in mice].
    Rolin O; Bouanchaud DH
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):742-5. PubMed ID: 3309807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adjunctive treatment of periodontitis with tetracycline and spiramycin.
    Al-Joburi W; Quee TC; Lautar C; Iugovaz I; Bourgouin J; Delorme F; Chan EC
    J Periodontol; 1989 Oct; 60(10):533-9. PubMed ID: 2681673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis.
    Emingil G; Atilla G; Sorsa T; Savolainen P; Baylas H
    J Periodontol; 2004 Oct; 75(10):1387-96. PubMed ID: 15562917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adjunctive roxithromycin therapy on interleukin-1β, transforming growth factor-β1 and vascular endothelial growth factor in gingival crevicular fluid of cyclosporine A-treated patients with gingival overgrowth.
    Gong Y; Lu J; Ding X; Yu Y
    J Periodontal Res; 2014 Aug; 49(4):448-57. PubMed ID: 23947915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of spiramycin with erythromycin for lower respiratory tract infections.
    De Cock L; Poels R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():159-63. PubMed ID: 3053570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of adjunctive Rodogyl therapy in the treatment of advanced periodontal disease. A longitudinal clinical and microbiologic study.
    Quee TC; Chan EC; Clark C; Lautar-Lemay C; Bergeron MJ; Bourgouin J; Stamm J
    J Periodontol; 1987 Sep; 58(9):594-601. PubMed ID: 3309251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of spiramycin and/or scaling on advanced periodontitis in humans.
    Bain CA; Beagrie GS; Bourgoin J; Delorme F; Holthuis A; Landry RG; Roy S; Schuller P; Singer D; Turnbull R
    J Can Dent Assoc; 1994 Mar; 60(3):209, 212-7. PubMed ID: 8156459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of elevated gingival crevicular fluid tumor necrosis factor-alpha and interleukin-8 levels in chronic hemodialysis patients with periodontal disease.
    Dağ A; Firat ET; Kadiroğlu AK; Kale E; Yilmaz ME
    J Periodontal Res; 2010 Aug; 45(4):445-50. PubMed ID: 20337890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
    Gürkan A; Cinarcik S; Hüseyinov A
    J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of spiramycin therapy on human periodontal disease.
    Sznajder N; Piovano S; Bernat MI; Flores L; Macchi R; Carraro JJ
    J Periodontal Res; 1987 Jul; 22(4):255-8. PubMed ID: 2957480
    [No Abstract]   [Full Text] [Related]  

  • 15. Spiramycin and erythromycin in the treatment of acute tonsillo-pharyngitis: a comparative study.
    Soekrawinata T; Ibrahim T; Driyatno E
    Curr Med Res Opin; 1984; 9(5):296-300. PubMed ID: 6397332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of spiramycin on plaque accumulation and gingivitis.
    Johnson RH; Rozanis J; Schofield ID; Haq MS
    Dent J; 1978 Nov; 44(10):456-60. PubMed ID: 365549
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of spiramycin on the interbacterial aggregation process in dental plaque formation].
    Rossetti B; Greco S; Gallo A; Chisari G; Lo Bue AM; Lupo G
    Stomatol Mediterr; 1990; 10(4):255-62. PubMed ID: 2097788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nonsurgical periodontal therapy on serum and gingival crevicular fluid cytokine levels during pregnancy and postpartum.
    Fiorini T; Susin C; da Rocha JM; Weidlich P; Vianna P; Moreira CH; Bogo Chies JA; Rösing CK; Oppermann RV
    J Periodontal Res; 2013 Feb; 48(1):126-33. PubMed ID: 22835005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of spiramycin and erythromycin in the treatment of experimental guinea pig legionellosis.
    Dournon E; Rajagopalan P
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():69-72. PubMed ID: 3182448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis.
    Emingil G; Han B; Ozdemir G; Tervahartiala T; Vural C; Atilla G; Baylas H; Sorsa T
    J Periodontal Res; 2012 Dec; 47(6):729-39. PubMed ID: 22571226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.